Pérez-Gil J
Dept Bioquímica, Fac Biología, Universidad Complutense, Madrid, Spain.
Pediatr Pathol Mol Med. 2001 Nov-Dec;20(6):445-69. doi: 10.1080/pdp.20.6.445.469.
Phospholipids have the major role in pulmonary surfacant concerning its biophysical function of reducing surface tension at the alveolar air-liquid interface to facilitate respiratory mechanics. However, the presence of some specific, highly hydrophobic polypeptides is essential to modulate the physical behavior of phospholipids and to promote rapid formation of stable surface films that are able to produce surface tensions in the range of 0 dynes/cm during cyclic compression. The present review summarizes the available data on the parameters governing lipid-protein interactions of the hydrophobic surfactant proteins SP-B and SP-C with the main surfactant phospholipids. Lipid-protein interactions in surfactant have been studied in vitro using preparations reconstituted with very different methodological procedures. Conclusions concerning the role of hydrophobic surfactant proteins on the assembly of lipid-protein surfactant structures in vivo have been revised in this respect. This review presents the knowledge available on the disposition of SP-B and SP-C in surfactant structures, the mode, extent, selectivity, and stoichiometry of their lipid-protein interactions, and the effect of the proteins on structure and dynamics of surfactant bilayers and monolayers. Some considerations are given to possible concerted actions, under physiological conditions, of both proteins SP-B and SP-C.
就其在肺泡气液界面降低表面张力以促进呼吸力学的生物物理功能而言,磷脂在肺表面活性物质中起主要作用。然而,一些特定的、高度疏水的多肽的存在对于调节磷脂的物理行为以及促进稳定表面膜的快速形成至关重要,这些表面膜在循环压缩过程中能够产生0达因/厘米范围内的表面张力。本综述总结了关于疏水表面活性蛋白SP-B和SP-C与主要表面活性磷脂之间脂质-蛋白质相互作用参数的现有数据。表面活性物质中的脂质-蛋白质相互作用已在体外使用通过非常不同的方法程序重构的制剂进行了研究。在这方面,关于疏水表面活性蛋白在体内脂质-蛋白质表面活性物质结构组装中的作用的结论已经得到修订。本综述介绍了关于SP-B和SP-C在表面活性物质结构中的分布、它们脂质-蛋白质相互作用的方式、程度、选择性和化学计量以及蛋白质对表面活性物质双层和单层的结构和动力学的影响的现有知识。还考虑了在生理条件下蛋白质SP-B和SP-C可能的协同作用。